TEMOZOLOMIDE for Malignant connective tissue neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 20 adverse event reports in the FDA FAERS database where TEMOZOLOMIDE was used for Malignant connective tissue neoplasm.

Most Reported Side Effects for TEMOZOLOMIDE

Side Effect	Reports	%	Deaths	Hosp.
Disease progression	1,562	9.2%	384	194
Death	1,403	8.3%	1,361	69
Off label use	1,357	8.0%	196	184
Product use in unapproved indication	1,353	8.0%	82	80
Thrombocytopenia	1,300	7.6%	236	410
Drug ineffective	1,131	6.7%	275	206
Nausea	1,071	6.3%	84	309
Neutropenia	809	4.8%	149	211
Malignant neoplasm progression	779	4.6%	208	125
Fatigue	766	4.5%	80	190
Vomiting	697	4.1%	84	272
Febrile neutropenia	616	3.6%	47	186
Anaemia	592	3.5%	75	113
Seizure	537	3.2%	63	320
Diarrhoea	469	2.8%	56	188